Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study
- PMID: 25966843
- PMCID: PMC4594706
- DOI: 10.1111/bcp.12681
Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study
Abstract
Aims: Selective serotonin re-uptake inhibitors (SSRIs), specifically citalopram and escitalopram, are thought to cause QTc prolongation, although studies have shown contradictory results. Nevertheless, a maximum citalopram dosage of 20 mg in high risk patients (e.g. >60 years of age) is recommended. We aimed to investigate the association between use of (individual) SSRIs and QTc in a population-based study in older adults.
Methods: This study, which was part of the prospective Rotterdam Study (period 1991-2012), included participants with up to five electrocardiograms (ECGs). We used linear mixed models to compare QTc F (QT corrected according to Fridericia) measured during use of individual SSRIs with QTc F measured during non-use of any antidepressant. For citalopram, analyses were additionally restricted to a maximum dosage of 20 mg in participants aged 60 years and older.
Results: We included 12 589 participants with a total of 26 620 ECGs of which 436 ECGs were made during SSRI use. The mean QTc F was similar during use of any drugs from the SSRI class and during non-use. After stratifying to individual SSRIs, ECGs recorded during use of citalopram had the longest QTc compared with ECGs recorded during non-use (+12.8 ms, 90% CI 7.5, 18.2). This result remained similar in the analysis comprising participants aged 60 years and older with a maximum prescribed daily dosage of 20 mg citalopram.
Conclusions: Although no SSRI class effect was observed, use of citalopram was associated with a longer QTc F, even after considering the recommended restrictions. Other SSRIs may not give a clinically relevant QTc F prolongation.
Keywords: electrocardiography; population surveillance; serotonin re-uptake inhibitors.
© 2015 The British Pharmacological Society.
Similar articles
-
Association between citalopram, escitalopram and QTc prolongation in a real-world geriatric setting.J Affect Disord. 2019 May 1;250:341-345. doi: 10.1016/j.jad.2019.02.060. Epub 2019 Feb 26. J Affect Disord. 2019. PMID: 30877856
-
QT interval prolongation in users of selective serotonin reuptake inhibitors in an elderly surgical population: a cross-sectional study.J Clin Psychiatry. 2014 Jan;75(1):15-21. doi: 10.4088/JCP.13m08397. J Clin Psychiatry. 2014. PMID: 24345304
-
Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation.J Clin Psychiatry. 2014 May;75(5):e441-9. doi: 10.4088/JCP.13r08672. J Clin Psychiatry. 2014. PMID: 24922496
-
[Citalopram and QT prolongation].Vnitr Lek. 2018 Winter;63(12):952-956. Vnitr Lek. 2018. PMID: 29334745 Review. Czech.
-
A comparison of the risk of QT prolongation among SSRIs.Ann Pharmacother. 2013 Oct;47(10):1330-41. doi: 10.1177/1060028013501994. Epub 2013 Oct 21. Ann Pharmacother. 2013. PMID: 24259697 Review.
Cited by
-
Clinically significant incidental QTc prolongation is subject to within-individual variability.Ann Noninvasive Electrocardiol. 2020 Mar;25(2):e12699. doi: 10.1111/anec.12699. Epub 2019 Sep 9. Ann Noninvasive Electrocardiol. 2020. PMID: 31498534 Free PMC article.
-
A comparative study of QT prolongation with serotonin reuptake inhibitors.Psychopharmacology (Berl). 2017 Oct;234(20):3075-3081. doi: 10.1007/s00213-017-4685-7. Epub 2017 Aug 3. Psychopharmacology (Berl). 2017. PMID: 28770276
-
Antidepressants and the risk of arrhythmia in elderly affected by a previous cardiovascular disease: a real-life investigation from Italy.Eur J Clin Pharmacol. 2018 Jan;74(1):119-129. doi: 10.1007/s00228-017-2352-x. Epub 2017 Oct 18. Eur J Clin Pharmacol. 2018. PMID: 29046942
-
Associated factors of potential drug-drug interactions and drug-food interactions in patients with multiple sclerosis.Ther Adv Chronic Dis. 2022 Aug 4;13:20406223221108391. doi: 10.1177/20406223221108391. eCollection 2022. Ther Adv Chronic Dis. 2022. PMID: 35959503 Free PMC article.
-
The Association Between Antidepressant Treatment and Heart Rate Deceleration Capacity in Patients With Mood disorders-A Potential New Predictor of Sudden Cardiac Death.Neuropsychiatr Dis Treat. 2025 Mar 18;21:597-607. doi: 10.2147/NDT.S507851. eCollection 2025. Neuropsychiatr Dis Treat. 2025. PMID: 40124177 Free PMC article.
References
-
- Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med. 1993;119:1187–97. - PubMed
-
- Myerburg RJ, Interian A, Jr, Mitrani RM, Kessler KM, Castellanos A. Frequency of sudden cardiac death and profiles of risk. Am J Cardiol. 1997;80:10F–19F. - PubMed
-
- Gorgels AP, Gijsbers C, de Vreede-Swagemakers J, Lousberg A, Wellens HJ. Out-of-hospital cardiac arrest - the relevance of heart failure. The Maastricht Circulatory Arrest Registry. Eur Heart J. 2003;24:1204–9. - PubMed
-
- Zipes DP, Wellens HJ. Sudden cardiac death. Circulation. 1998;98:2334–51. - PubMed
-
- Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350:1013–22. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources